Fingerprint
Dive into the research topics of 'Phase I and pharmacologic study of the specific matrix metalloproteinase inhibitor BAY 12-9566 on a protracted oral daily dosing schedule in patients with solid malignancies'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically